Notice: This company has been marked as potentially delisted and may not be actively trading. ProSomnus (OSA) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsHeadlinesOwnershipTrends Get the Latest News and Ratings for OSA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ProSomnus and its competitors. Enter your email to sign up for newsletter Sign Up OSA Analyst Ratings Over TimeTypeCurrent Forecast12/23/23 to 12/22/241 Month Ago11/23/23 to 11/22/243 Months Ago9/24/23 to 9/23/241 Year Ago12/23/22 to 12/23/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)2 Buy rating(s)2 Buy rating(s)Hold0 Hold rating(s)0 Hold rating(s)1 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$2.00$2.00$2.33$2.50Forecasted UpsideN/A14,605.88% Upside17,056.86% Upside177.76% UpsideConsensus RatingBuyBuyModerate BuyModerate Buy Your bank is lying to you. (Ad)You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.View the best savings account rates here OSA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History OSA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table ProSomnus Stock vs. The CompetitionTypeProSomnusMedical CompaniesS&P 500Consensus Rating Score 3.00 2.81 2.51Consensus RatingBuyModerate BuyModerate BuyPredicted UpsideN/A25,827.32% Upside14.53% UpsideNews Sentiment RatingNeutral NewsSee Recent OSA NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails1/22/2024Alliance Global Partners1 of 5 stars Initiated CoverageBuy$2.00+194.11%11/10/2023Craig Hallum3 of 5 stars Reiterated RatingBuy ➝ Hold$1.00+177.77%9/26/2023Roth Mkm1 of 5 stars Lower TargetBuy ➝ Buy$6.00 ➝ $4.00+308.16%4/18/2023Roth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. HenrySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:02 AM ET. OSA Forecast - Frequently Asked Questions What is ProSomnus' forecast for 2025? According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for ProSomnus is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. Should I buy or sell ProSomnus stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProSomnus in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" OSA shares. Does ProSomnus's stock price have much upside? According to analysts, ProSomnus's stock has a predicted upside of ∞ based on their 12-month stock forecasts. Do Wall Street analysts like ProSomnus more than its competitors? Analysts like ProSomnus more than other "medical" companies. The consensus rating for ProSomnus is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OSA compares to other companies. Stock Forecasts and Research Tools Related Companies NYXH Stock Forecast STVN Stock Forecast SYK Stock Forecast BSX Stock Forecast MMM Stock Forecast BDX Stock Forecast RMD Stock Forecast DXCM Stock Forecast WST Stock Forecast PODD Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Your bank is lying to you. (Ad)You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.View the best savings account rates here This page (NASDAQ:OSA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProSomnus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProSomnus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.